EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity

Moritz Bewarder iD, Konstantinos Christofyllakis, Milena Petersen, Gerhard Held iD, Sigrun Smola iD, Gabi Carbon, Birgit Bette, Annika Link, Maximilian Kiefer, Joerg Thomas Bittenbring iD, Igor Age Kos, Vadim Lesan und 3 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Moritz Bewarder und 14 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine I, Saarland University Medical Center, 66421 Homburg, Germany. Hauptthemen laut MEDLINE: Cytomegalovirus, Killer Cells, Natural, Receptors, Antigen, T-Cell, Cytomegalovirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche José Carreras Leukämie-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytomegalovirus (CMV) reactivation after stem cell or solid organ transplantation remains a major cause of morbidity and mortality in this setting. T-cell receptor (TCR)-like antibodies bind to intracellular peptides presented in major histocompatibility complex (MHC) molecules on the cell surface and may have the potential to replace T-cell function in immunocompromised patients. Three previously selected CMV-specific, human leukocyte antigen (HLA)-restricted (HLA-A*0101, HLA-A*0201 and HLA-B*0702) Fab-antibodies (A6, C1 and C7) were produced as IgG antibodies with Fc optimization. All antibodies showed specific binding to CMV peptide-loaded tumor cell lines and primary fibroblasts expressing the corresponding MHC-I molecules, leading to specific target cell lysis after the addition of natural killer (NK) cells. When deployed in combination as an antibody pool against target cells expressing more than one matching HLA allele, cytotoxic effects were amplified accordingly. CMV-specific TCR-like antibodies were also able to mediate their cytotoxic effects through neutrophils, which is important considering the delayed recovery of NK cells after stem cell transplantation. When tested on patient blood obtained during CMV reactivation, CMV-specific antibodies were able to bind to and induce cytotoxic effects in lymphocytes. CMV-specific TCR-like antibodies may find application in patients with CMV reactivation or at risk of CMV reactivation. In contrast to previous HLA/peptide-directed therapeutic approaches, the concept of a TCR-like antibody repertoire covering more than one HLA allele would make this therapeutic format available to a much larger group of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusKiller Cells, NaturalReceptors, Antigen, T-CellCytomegalovirus InfectionsAntibody-Dependent Cell CytotoxicityHumansLeukocytesAntibodies, Viral

Stichwörter der Autor:innen

T-cell receptor (TCR)-like antibodiescytomegalovirushuman leukocyte antigen (HLA) allelessolid organ transplantationstem cell transplantation

Substanzen

Receptors, Antigen, T-CellAntibodies, Viral

Autor:innen und Institutionen

  • Internal Medicine I, Saarland University Medical Center, 66421 Homburg, Germany.
  • Internal Medicine I, Westpfalz-Klinikum Kaiserslautern, 67655 Kaiserslautern, Germany.
  • Institute of Virology, Saarland University Medical Center, 66421 Homburg, Germany.
  • Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarland University Campus, 66123 Saarbrucken, Germany.

ORCID-Profile: Moritz Bewarder, Gerhard Held, Sigrun Smola, Joerg Thomas Bittenbring, Frank Neumann

Förderung

  • Deutsche José Carreras Leukämie-Stiftung

Zitieren

APA

Bewarder, M., Christofyllakis, K., Petersen, M., Held, G., Smola, S., Carbon, G., Bette, B., Link, A., Kiefer, M., Bittenbring, J. T., Kos, I. A., Lesan, V., Kaddu-Mulindwa, D., Thurner, L., & Neumann, F. (2024). Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312908

Vancouver

Bewarder M, Christofyllakis K, Petersen M, Held G, Smola S, Carbon G, et al. Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312908

BibTeX
@article{Bewarder2024,
  author = {Bewarder, Moritz and Christofyllakis, Konstantinos and Petersen, Milena and Held, Gerhard and Smola, Sigrun and Carbon, Gabi and Bette, Birgit and Link, Annika and Kiefer, Maximilian and Bittenbring, Joerg Thomas and Kos, Igor Age and Lesan, Vadim and Kaddu-Mulindwa, Dominic and Thurner, Lorenz and Neumann, Frank},
  title = {Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312908}
}
Kostenlos starten →